Achieve Life Sciences, Inc. (ACHV)

USD 4.0

(-3.85%)

Market Cap (In USD)

137.55 Million

Revenue (In USD)

-

Net Income (In USD)

-29.81 Million

Avg. Volume

203.89 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.2-5.59
PE
-
EPS
-
Beta Value
1.583
ISIN
US0044685008
CUSIP
004468203
CIK
949858
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Richard A. B. Stewart
Employee Count
-
Website
https://www.achievelifesciences.com
Ipo Date
1995-10-12
Details
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.